Harvard Bioscience Inc (HBIO) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Harvard Bioscience Inc   (NASDAQ: HBIO)
 

Harvard Bioscience Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Harvard Bioscience Inc inventory turnover ratio, the Harvard Bioscience Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 1.76 in the third quarter 2026, yet the ratio remained below the average, as HBIO's market remain challenging.Average inventory processing period, for the Harvard Bioscience Inc in Sep 30 2026 quarter, has decreased to 207 days, compare to 213 days, in the Jun 30 2026 quarter.

Within Healthcare sector 228 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1392 in the second quarter 2026, to 1693.

HBIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Harvard Bioscience Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HBIO Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 8.73 % -0.11 % -2.68 % -10.5 % -16.88 %
Y / Y Cost of Sales Growth 23.61 % 26.21 % -11.11 % -8.33 % -11.11 %
Inventory Turnover Ratio (TTM) 1.76 1.71 1.61 1.65 1.65
HBIO's Total Ranking # 1693 # 1392 # 1371 # 1015 #
Average inventory processing period 208 214 226 222 222
Seq. Inventory Growth 5.67 % 0.11 % 6.73 % -3.7 % -2.93 %
Seq. Cost of Sales Growth -2.06 % 26.21 % -27.27 % 37.5 % 0 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 13
Healthcare Sector # 229
Overall Market # 1693

Inventory Turnover Ratio Statistics
High Average Low
3.51 2.31 1.58
(Sep 30 2014)   (Sep 30 2024)



HBIO Company Profile >> Back to HBIO Efficiency Comparisons >> Compare HBIO Inventory Turnover Ratio to its Competitors

Financial Statements
Harvard Bioscience Inc 's Inventories $ 23 Millions Visit HBIO's Balance sheet
Harvard Bioscience Inc 's Cost of Revenues TTM $ 39 Millions Visit HBIO's Income Statement
What are HBIO's Sales? Visit HBIO's Sales by Segment

Other Inventory Turnover Ratios
Harvard Bioscience Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HBIO's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HBIO's Competitors
Inventory Turnover Ratio for HBIO's Suppliers
Inventory Turnover Ratio for HBIO's Customers

You may also want to know
HBIO's Sales Growth Rates HBIO's Pe Price to earnings ratio HBIO's Receivables Turnover Ratio HBIO's Stock Quote
HBIO's Net Income Growth Rates HBIO's Ps Price to Sales ratio HBIO's Sales per Employee HBIO's Asset Turnover Ratio
HBIO's Net Margin HBIO's Pb Price to Book ratio HBIO's Financial Strength Ratios HBIO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Elite Pharmaceuticals Inc   3.48 $ 80.918  Millions$ 23  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Abbott Laboratories  2.95 $ 20,765.000  Millions$ 7,032  Millions
Revvity Inc  2.93 $ 1,122.448  Millions$ 384  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Zai Lab Limited  2.91 $ 200.083  Millions$ 69  Millions
Amneal Pharmaceuticals Inc   2.90 $ 1,910.255  Millions$ 658  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Ani Pharmaceuticals Inc  2.87 $ 405.540  Millions$ 142  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions

Date modified: 2026-11-11T13:45:50+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.